Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
Go back to Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 330.44 +8.26 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.18 | 52 Week High | $141.32 | |||
| Open | $324.49 | 52 Week Low | $97.79 | |||
| Day High | $331.20 | P/E | 52.87 | |||
| Day Low | $323.41 | EPS | $6.25 | |||
| Volume | 518,283 | |||||
